Exagen Inc. (XGN)

USD 5.52

(-4.83%)

Total Debt Summary of Exagen Inc.

  • Exagen Inc.'s latest annual total debt in 2023 was 23.72 Million USD , down -31.25% from previous year.
  • Exagen Inc.'s latest quarterly total debt in 2024 Q2 was 23.87 Million USD , up 1.7% from previous quarter.
  • Exagen Inc. reported annual total debt of 34.5 Million USD in 2022, up 25.56% from previous year.
  • Exagen Inc. reported annual total debt of 27.47 Million USD in 2021, up 3.07% from previous year.
  • Exagen Inc. reported quarterly total debt of 23.87 Million USD for 2024 Q2, up 1.7% from previous quarter.
  • Exagen Inc. reported quarterly total debt of 23.72 Million USD for 2023 Q4, down -2.06% from previous quarter.

Annual Total Debt Chart of Exagen Inc. (2023 - 2012)

Historical Annual Total Debt of Exagen Inc. (2023 - 2012)

Year Total Debt Total Debt Growth
2023 23.72 Million USD -31.25%
2022 34.5 Million USD 25.56%
2021 27.47 Million USD 3.07%
2020 26.65 Million USD 3.11%
2019 25.85 Million USD 4.68%
2018 24.69 Million USD 31.12%
2017 18.83 Million USD 0.0%
2015 25.9 Million USD 39.89%
2014 18.51 Million USD 107.71%
2013 8.91 Million USD 243.55%
2012 2.59 Million USD 0.0%

Peer Total Debt Comparison of Exagen Inc.

Name Total Debt Total Debt Difference
Bionano Genomics, Inc. 87.94 Million USD 73.028%
Prenetics Global Limited 2.36 Million USD -901.145%
Star Equity Holdings, Inc. 3.6 Million USD -557.273%
CareDx, Inc 34.22 Million USD 30.683%
Exact Sciences Corporation 2.55 Billion USD 99.071%
Inotiv, Inc. 417.64 Million USD 94.32%
Guardant Health, Inc. 1.35 Billion USD 98.248%
Biodesix, Inc. 60.69 Million USD 60.915%
BioNexus Gene Lab Corp. 133.39 Thousand USD -17682.526%
Precipio, Inc. 1.11 Million USD -2025.538%
iSpecimen Inc. 196.24 Thousand USD -11987.503%
Natera, Inc. 441.99 Million USD 94.633%
Aspira Women's Health Inc. 2.26 Million USD -946.823%
Standard BioTools Inc. 98.21 Million USD 75.847%
23andMe Holding Co. 76.51 Million USD 68.998%
Castle Biosciences, Inc. 15.31 Million USD -54.938%
Personalis, Inc. 48.96 Million USD 51.552%
Aclaris Therapeutics, Inc. 426 Thousand USD -5468.31%
Applied DNA Sciences, Inc. 1.23 Million USD -1816.446%
OpGen, Inc. 13.04 Million USD -81.858%
T2 Biosystems, Inc. 49.49 Million USD 52.077%
Myriad Genetics, Inc. 145 Million USD 83.641%
ICON Public Limited Company 3.93 Billion USD 99.398%
NeoGenomics, Inc. 611.67 Million USD 96.122%
Star Equity Holdings, Inc. 3.6 Million USD -557.273%
IDEXX Laboratories, Inc. 947.88 Million USD 97.497%
RadNet, Inc. 1.49 Billion USD 98.409%
MDxHealth SA 41.26 Million USD 42.515%
Psychemedics Corporation 2.29 Million USD -932.245%
Illumina, Inc. 2.26 Billion USD 98.951%
Check-Cap Ltd. - USD -Infinity%
Twist Bioscience Corporation 94.06 Million USD 74.783%
DarioHealth Corp. 29.54 Million USD 19.701%
Fulgent Genetics, Inc. 14.9 Million USD -59.127%
Sera Prognostics, Inc. 1.85 Million USD -1176.695%
ENDRA Life Sciences Inc. 394.4 Thousand USD -5914.407%
OPKO Health, Inc. 326.56 Million USD 92.736%
Medpace Holdings, Inc. 142.12 Million USD 83.309%
Neogen Corporation 906.23 Million USD 97.382%
Intelligent Bio Solutions Inc. 871.44 Thousand USD -2622.046%
Prenetics Global Limited 2.36 Million USD -901.145%
Mainz Biomed B.V. 7.42 Million USD -219.656%
bioAffinity Technologies, Inc. 1.57 Million USD -1402.623%
Trinity Biotech plc 67.42 Million USD 64.82%
Neuronetics, Inc. 62.47 Million USD 62.031%
Sotera Health Company 2.32 Billion USD 98.981%
bioAffinity Technologies, Inc. 1.57 Million USD -1402.623%